|
Journal of Histochemistry and Cytochemistry, Vol. 49, 1143-1154, September 2001, Copyright © 2001, The Histochemical Society, Inc.
Prolyl 4-hydroxylase Isoenzymes I and II Have Different Expression Patterns in Several Human Tissues
Ritva Nissia,
Helena AutioHarmainenb,
Pia Marttilaa,
Raija Sormunenb, and
Kari I. Kivirikkoa
a Collagen Research Unit, Biocenter and Department of Medical Biochemistry, University of Oulu
b Department of Pathology, University of Oulu, Oulu, Finland
Correspondence to:
Kari I. Kivirikko, Collagen Research Unit, Biocenter and Dept. of Medical Biochemistry, University of Oulu, PO Box 5000, FIN 90014 Oulu, Finland. E-mail: kari.kivirikko@oulu.fi
Prolyl 4-hydroxylase plays a central role in the synthesis of all collagens. We have previously reported that the recently identified Type II isoenzyme is its main form in chondrocytes and possibly in capillary endothelial cells, while Type I is the main form in many other cell types. We report here that the Type II isoenzyme is clearly the main form in capillary endothelial cells and also in cultured umbilical vein endothelial cells, whereas no Type I isoenzyme could be detected in these cells by immunostaining or Western blotting. The Type II isoenzyme was also the main form in cells of the developing glomeruli in the fetal kidney and tubular structures of collecting duct caliber in both fetal and adult kidney, in occasional sinusoidal structures and epithelia of the bile ducts in the liver, and in some cells of the decidual membrane that probably represented invasive cytotrophoblasts in the placenta. Osteoblasts in a fetal calvaria, i.e., a bone developing by intramembranous ossification, stained strongly for both types of isoenzyme. The Type I isoenzyme was the main form in undifferentiated interstitial mesenchymal cells of the developing kidney, for example, and in fibroblasts and fibroblastic cells in many tissues. Skeletal myocytes and smooth muscle cells appeared to have the Type I isoenzyme as their only prolyl 4-hydroxylase form. Hepatocytes expressed small amounts of the Type I enzyme and very little if any Type II, the Type I expression being increased in malignant hepatocytes and cultured hepatoblastoma cells. The data suggest that the Type I isoenzyme is expressed especially by cells of mesenchymal origin and in developing and malignant tissues, whereas the Type II isoenzyme is expressed, in addition to chondrocytes and osteoblasts, by more differentiated cells, such as endothelial cells and cells of epithelial structures. (J Histochem Cytochem 49:11431153, 2001)
Key Words:
prolyl hydroxylase, collagen, enzyme, chondrocytes, endothelial cells

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Keskiaho, L. Kukkola, A. P. Page, A. D. Winter, J. Vuoristo, R. Sormunen, R. Nissi, P. Riihimaa, and J. Myllyharju
Characterization of a Novel Caenorhabditis elegans Prolyl 4-Hydroxylase with a Unique Substrate Specificity and Restricted Expression in the Pharynx and Excretory Duct
J. Biol. Chem.,
April 18, 2008;
283(16):
10679 - 10689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zhang, M.-X. Zhang, Y. H. Shen, J. K. Burks, Y. Zhang, J. Wang, S. A. LeMaire, K. Yoshimura, H. Aoki, J. S. Coselli, et al.
TNF-{alpha} Suppresses Prolyl-4-Hydroxylase {alpha}1 Expression via the ASK1-JNK-NonO Pathway
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2007;
27(8):
1760 - 1767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Holster, O. Pakkanen, R. Soininen, R. Sormunen, M. Nokelainen, K. I. Kivirikko, and J. Myllyharju
Loss of Assembly of the Main Basement Membrane Collagen, Type IV, but Not Fibril-forming Collagens and Embryonic Death in Collagen Prolyl 4-Hydroxylase I Null Mice
J. Biol. Chem.,
January 26, 2007;
282(4):
2512 - 2519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Grimmer, N. Balbus, U. Lang, T. Aigner, T. Cramer, L. Muller, B. Swoboda, and D. Pfander
Regulation of Type II Collagen Synthesis during Osteoarthritis by Prolyl-4-Hydroxylases: Possible Influence of Low Oxygen Levels
Am. J. Pathol.,
August 1, 2006;
169(2):
491 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen, Y. H. Shen, X. Wang, J. Wang, Y. Gan, N. Chen, J. Wang, S. A. LeMaire, J. S. Coselli, and X. L. Wang
Human Prolyl-4-hydroxylase {alpha}(I) Transcription Is Mediated by Upstream Stimulatory Factors
J. Biol. Chem.,
April 21, 2006;
281(16):
10849 - 10855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fahling, R. Mrowka, A. Steege, P. Martinka, P. B. Persson, and B. J. Thiele
Heterogeneous Nuclear Ribonucleoprotein-A2/B1 Modulate Collagen Prolyl 4-Hydroxylase, {alpha} (I) mRNA Stability
J. Biol. Chem.,
April 7, 2006;
281(14):
9279 - 9286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pekkala, R. Hieta, U. Bergmann, K. I. Kivirikko, R. K. Wierenga, and J. Myllyharju
The Peptide-Substrate-binding Domain of Collagen Prolyl 4-Hydroxylases Is a Tetratricopeptide Repeat Domain with Functional Aromatic Residues
J. Biol. Chem.,
December 10, 2004;
279(50):
52255 - 52261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kukkola, R. Hieta, K. I. Kivirikko, and J. Myllyharju
Identification and Characterization of a Third Human, Rat, and Mouse Collagen Prolyl 4-Hydroxylase Isoenzyme
J. Biol. Chem.,
November 28, 2003;
278(48):
47685 - 47693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hieta, L. Kukkola, P. Permi, P. Pirila, K. I. Kivirikko, I. Kilpelainen, and J. Myllyharju
The Peptide-Substrate-binding Domain of Human Collagen Prolyl 4-Hydroxylases: BACKBONE ASSIGNMENTS, SECONDARY STRUCTURE, AND BINDING OF PROLINE-RICH PEPTIDES
J. Biol. Chem.,
September 12, 2003;
278(37):
34966 - 34974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Van Den Diepstraten, K. Papay, Z. Bolender, A. Brown, and J. G. Pickering
Cloning of a Novel Prolyl 4-Hydroxylase Subunit Expressed in the Fibrous Cap of Human Atherosclerotic Plaque
Circulation,
August 5, 2003;
108(5):
508 - 511.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 2001
|
|
|